Product Information
DUTASTERIDE 0.5 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1570 per EA under NDC 59651002190. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Nov 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651002190
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DUTASTERIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202660FDA Approved
11/20/2015
TE Code
AB
On Market Since
1/20/2023
Pharmacological Classes
Price Statistics
The NADAC for DUTASTERIDE 0.5 MG CAPSULE has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1570 per EA |
|---|---|
| All-time high | $0.1976 (Jul 10, 2024) |
| All-time low | $0.1437 (Nov 20, 2024) |
| 52-week high | $0.1787 |
| 52-week low | $0.1570 |
| Median price | $0.1775 |
| Average price | $0.1772 |
| Largest weekly change | -25.9% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dutasteride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
5-alpha Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DUTASTERIDE 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DUTASTERIDE 0.5 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1570 per EA (NDC 59651002190), effective Sep 30, 2026.
How has the price of DUTASTERIDE 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DUTASTERIDE 0.5 MG CAPSULE has declined 5.2%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for DUTASTERIDE 0.5 MG CAPSULE?
Since Jun 5, 2024, the NADAC for DUTASTERIDE 0.5 MG CAPSULE has ranged from a low of $0.1437 (Nov 20, 2024) to a high of $0.1976 (Jul 10, 2024), with a median of $0.1775 per EA.
Are there cheaper alternatives to DUTASTERIDE 0.5 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DUTASTERIDE 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DUTASTERIDE 0.5 MG CAPSULE?
DUTASTERIDE 0.5 MG CAPSULE (NDC 59651002190) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.